Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing–remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

Richard Nixon,Gorana Capkun-Niggli,Niklas Bergvall,Sofia Dias

Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing–remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

2015

Richard Nixon
Gorana Capkun-Niggli
Niklas Bergvall
Sofia Dias

Dear EditorIn this recent article published in CMRO, Hutchinson et al. conducted network meta-analyses between BG-12 (dimethyl fumarate) and other disease-modifying treatments (DMTs) and concluded:...

Keywords:

Multiple sclerosis
Alternative medicine
Anesthesia
Disease
Medicine
Dimethyl fumarate
Dermatology
relapsing remitting
Diabetes mellitus
treatment comparison

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations